Correspondence Address:
Sarvesswaran Prakash
Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Tirunelveli, Tamil Nadu
India

Full Text



Chlorpromazine is used in treating schizophrenia but on long-term usage can cause irreversible ocular toxicity affecting the cornea, conjunctiva, and lens.[1] It is hypothesised that phenothiazines denature proteins when exposed to light; the proteins then become opacified and are deposited in ocular tissues.[2],[3],[4],[5] Herewith, we report a 54-year-old chronic schizophrenia patient who was treated with chlorpromazine hydrochloride 300 mg/d for the past 15 years. On examination, the visual acuity was 6/9 in both eyes. On slit lamp examination, both eyes revealed discrete yellow refractile deposits on the corneal stroma and characteristic bilateral stellate-shaped anterior sub-capsular cataract [Figure 1]. Fundus examination was normal in both eyes.{Figure 1}

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consents forms. In the form patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References